Berkshire Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,180
| Closed | -$211K | – | 236 |
|
|
2023
Q4 | $211K | Buy |
+4,180
| New | +$211K | 0.01% | 222 |
|
|
2022
Q3 | – | Sell |
-5,596
| Closed | -$207K | – | 225 |
|
|
2022
Q2 | $207K | Sell |
5,596
-4,143
| -43% | -$153K | 0.01% | 214 |
|
|
2022
Q1 | $361K | Buy |
9,739
+500
| +5% | +$18.5K | 0.02% | 156 |
|
|
2021
Q4 | $281K | Sell |
9,239
-3,821
| -29% | -$116K | 0.02% | 207 |
|
|
2021
Q3 | $438K | Buy |
13,060
+1,661
| +15% | +$55.7K | 0.03% | 174 |
|
|
2021
Q2 | $455K | Sell |
11,399
-949
| -8% | -$37.9K | 0.03% | 164 |
|
|
2021
Q1 | $555K | Hold |
12,348
| – | – | 0.04% | 147 |
|
|
2020
Q4 | $698K | Buy |
+12,348
| New | +$698K | 0.05% | 131 |
|
|
2020
Q3 | – | Sell |
-3,986
| Closed | -$235K | – | 169 |
|
|
2020
Q2 | $235K | Sell |
3,986
-7,530
| -65% | -$444K | 0.02% | 149 |
|
|
2020
Q1 | $544K | Buy |
11,516
+8,007
| +228% | +$378K | 0.06% | 124 |
|
|
2019
Q4 | $212K | Sell |
3,509
-352
| -9% | -$21.3K | 0.02% | 190 |
|
|
2019
Q3 | $231K | Hold |
3,861
| – | – | 0.02% | 191 |
|
|
2019
Q2 | $248K | Buy |
3,861
+878
| +29% | +$56.4K | 0.02% | 186 |
|
|
2019
Q1 | $242K | Buy |
+2,983
| New | +$242K | 0.02% | 204 |
|